Telesis Bio, Inc. (TBIO)
OTCMKTS
· Delayed Price · Currency is USD
1.500
-0.200 (-11.76%)
Oct 25, 2024, 3:30 PM EDT
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $3.01 million as of October 25, 2024. Its market cap has decreased by -90.04% in one year.
Market Cap
3.01M
Enterprise Value
58.83M
Revenue
19.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
Market Cap Chart
Since June 18, 2021, Telesis Bio's market cap has decreased from 522.24M to 3.01M, a decrease of -99.42%. That is a compound annual growth rate of -78.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 24, 2024 | 3.01M | -74.81% |
Dec 29, 2023 | 11.96M | -66.23% |
Dec 30, 2022 | 35.43M | -88.81% |
Dec 31, 2021 | 316.52M | -39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 19.03B |
Telix Pharmaceuticals Limited | 4.64B |
Elekta AB (publ) | 2.50B |
Ryman Healthcare Limited | 2.06B |
Verano Holdings Corp. | 1.28B |
Vireo Growth Inc. | 104.78M |
Medexus Pharmaceuticals Inc. | 46.11M |